Search alternatives:
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
-
381
-
382
-
383
-
384
-
385
-
386
-
387
-
388
Decreased Sho levels in ScN2a-Sho cells.
Published 2011“…(<b>B</b>) In heterogeneous ScN2a-Sho cells, Sho levels were not decreased. However, upon further subcloning of ScN2a-Sho cells to obtain a more uniform population of infected cells (ScN2a-Sho-1 and ScN2a-Sho-2 subclones), a notable decrease in Sho levels was observed. …”
-
389
-
390
Structure of a trial.
Published 2024“…While learning effects may have negated the impact of mental fatigue across the 5 experimental blocks, a significant decrease in performance was observed within blocks. …”
-
391
TMEM16A knockdown decreased activation of the MEK-ERK1/2 pathway and expression of cyclin D1.
Published 2014“…<p>Western blot results show inhibition of TMEM16A led to a decrease in phospho-MEK, phospho-ERK1/2 and cyclin D1. …”
-
392
-
393
-
394
-
395
-
396
-
397
Linear regression analysis between ω3-/ω6-PUFA ratio, Body Mass Index (BMI) and pSTAT3 decrease.
Published 2013“…<p>Correlation between the ω3-/ω6-PUFA ratio and the percentage of pSTAT3 decrease after DHA treatment in control subjects (n=10) (<b>A</b>) and cancer subjects (n=14) (<b>B</b>). …”
-
398
-
399
-
400